Signal2026-08-11
ClinicalTrials.gov

[PHASE1] Impact of GLP-1 Receptor Agonist Therapy on Alcohol Pharmacokinetics

Part of

Innovative Obesity And Metabolic Therapies

Open primary sourceRead on Substack